Finance

Lists
MKKGY:OTCMKTS
Merck KGaA
$32.83
-0.76%
(-0.25) 1D
Nov 18, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MKKGY...
Open
$33.03
High
$33.12
Low
$32.78
Mkt. cap
71.53B
Avg. vol.
90.35K
Volume
192.03K
Dividend
1.57%
Quarterly dividend
$0.13
Ex-dividend date
Apr 27, 2026
P/E ratio
33.75
52-wk high
$34.19
52-wk low
$23.73
EPS
$0.97
Beta
0.90
Shares outstanding
646.21M
No. of employees
62K
Open
$33.03
High
$33.12
Low
$32.78
Mkt. cap
71.53B
Avg. vol.
90.35K
Volume
192.03K
Dividend
1.57%
Quarterly dividend
$0.13
Ex-dividend date
Apr 27, 2026
P/E ratio
33.75
52-wk high
$34.19
52-wk low
$23.73
EPS
$0.97
Beta
0.90
Shares outstanding
646.21M
No. of employees
62K
News stories
From web sources and news partners
Profile
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Shizuoka and Beijing, as well as other Research and Development units in Taiwan, France, Israel, South Korea, India, and the UK. Merck pioneered the commercial manufacture of morphine in the 19th century and for a time held a virtual monopoly on cocaine. Merck was privately owned until going public on the Frankfurt Stock Exchange in 1995 and is listed on the DAX index of Germany's top companies. The Merck family still controls a majority of 70.3% of the company's shares. Wikipedia
About Merck KGaA
CEO-
Employees61.9K
Founded1668
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
5.25B
5.13B
5.43B
5.63B
Cost of goods sold
2.20B
2.07B
2.27B
2.25B
Cost of revenue
2.20B
2.07B
2.27B
2.25B
Research and development expenses
634.00M
657.70M
684.00M
635.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.54B
1.52B
1.56B
1.58B
Operating expense
2.12B
2.13B
2.41B
2.73B
Total operating expenses
4.32B
4.20B
4.68B
4.97B
Operating income
926.00M
935.40M
753.00M
653.00M
Other non operating income
4.00M
-100.00K
-1.00M
-
EBT including unusual items
401.00M
868.70M
640.00M
591.00M
EBT excluding unusual items
1.10B
867.50M
640.00M
591.00M
Income tax expense
77.00M
200.00M
146.00M
141.00M
Effective tax rate
19.20%
23.02%
22.81%
23.86%
Other operating expenses
-50.00M
-45.40M
164.00M
515.00M
Net income
319.00M
659.40M
490.00M
450.00M
Net profit margin
6.08%
12.84%
9.02%
8.00%
Earnings per share
-
-
2.16
2.32
Interest and investment income
21.00M
21.20M
25.00M
57.00M
Interest expense
-43.00M
-80.60M
-137.00M
-119.00M
Net interest expenses
-22.00M
-59.40M
-112.00M
-62.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.31B
1.42B
1.25B
1.62B
Gain or loss from assets sale
6.00M
-41.90M
1.00M
-
Upcoming events
AI content may include mistakes. Learn more
Google apps